Search alternatives:
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a mean » _ mean (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a mean » _ mean (Expand Search)
-
13781
Nodal knockdown decreases proliferation and increases apoptosis in aggressive MDA-MB-231 breast cancer cells.
Published 2012“…MDA-MB-231 cells transfected with a Nodal-targeted shRNA (231+shNodal) exhibited a significant decrease in proliferation over 3 days compared to cells transfected with a scrambled Control shRNA (231+shControl) (n = 3; p = 0.047). …”
-
13782
-
13783
Changes in salivary oxytocin levels and bonding disorder in women from late pregnancy to early postpartum: A pilot study
Published 2019“…Their mean salivary oxytocin levels significantly increased from late pregnancy (36–39 gestation weeks) up to 1 day postpartum and then decreased until 5 days postpartum. …”
-
13784
-
13785
-
13786
-
13787
-
13788
-
13789
-
13790
-
13791
-
13792
CD5-CK2 Signaling Modulates Erk Activation and Thymocyte Survival
Published 2016“…Using a gene-targeted mouse in which the CD5-CK2BD is selectively ablated (CD5-ΔCK2BD), we determined that loss of function of CD5-CK2 signaling in a MHC-II selecting TCR transgenic (OT-II) mouse resulted in decrease in double positive (DP) thymocytes, which correlated with enhanced apoptosis. …”
-
13793
-
13794
-
13795
-
13796
Image1_Restricting Glutamine Uptake Enhances NSCLC Sensitivity to Third-Generation EGFR-TKI Almonertinib.TIF
Published 2021“…The combination of SLC1A5 inhibitor V9302 and Almonertinib had a synergistic inhibitory effect on the proliferation of NSCLC. …”
-
13797
Patients’ clinicopathological characteristics.
Published 2025“…The mean total operation time was 272.50±66.74 minutes while mean oncologic mastectomy was 155.61±43.21 minutes. …”
-
13798
Oncologic results.
Published 2025“…The mean total operation time was 272.50±66.74 minutes while mean oncologic mastectomy was 155.61±43.21 minutes. …”
-
13799
Perioperative parameters.
Published 2025“…The mean total operation time was 272.50±66.74 minutes while mean oncologic mastectomy was 155.61±43.21 minutes. …”
-
13800
Perioperative complications.
Published 2025“…The mean total operation time was 272.50±66.74 minutes while mean oncologic mastectomy was 155.61±43.21 minutes. …”